107 related articles for article (PubMed ID: 32911313)
1. Quantitative perfusion parameters of benign inflammatory breast pathologies: A descriptive study.
Ucar EA; Durur-Subasi I; Yilmaz KB; Arikok AT; Hekimoglu B
Clin Imaging; 2020 Dec; 68():249-256. PubMed ID: 32911313
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
Cetinkaya E; Aralasmak A; Atasoy B; Tokdemir S; Toprak H; Toprak A; Kurtcan S; Alkan A
Curr Med Imaging; 2022; 18(10):1099-1105. PubMed ID: 35331119
[TBL] [Abstract][Full Text] [Related]
3. Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla.
Liu F; Wang M; Li H
World J Surg Oncol; 2018 Dec; 16(1):239. PubMed ID: 30577820
[TBL] [Abstract][Full Text] [Related]
4. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
[TBL] [Abstract][Full Text] [Related]
5. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
6. The Use of Dynamic Contrast-Enhanced Perfusion MRI in Differentiating Benign and Malignant Thyroid Nodules.
Sakat MS; Sade R; Kilic K; Gözeler MS; Pala O; Polat G; Kantarcı M
Indian J Otolaryngol Head Neck Surg; 2019 Oct; 71(Suppl 1):706-711. PubMed ID: 31742047
[TBL] [Abstract][Full Text] [Related]
7. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type.
Yim H; Kang DK; Jung YS; Jeon GS; Kim TH
Magn Reson Imaging; 2016 Jan; 34(1):60-5. PubMed ID: 26234500
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.
Ma ZS; Wang DW; Sun XB; Shi H; Pang T; Dong GQ; Zhang CQ
Exp Ther Med; 2015 Mar; 9(3):913-918. PubMed ID: 25667653
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
[TBL] [Abstract][Full Text] [Related]
10. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
11. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
An YS; Kang DK; Jung YS; Han S; Kim TH
Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions.
Dong J; Wang D; Ma Z; Deng G; Wang L; Zhang J
Exp Ther Med; 2017 Mar; 13(3):1069-1073. PubMed ID: 28450944
[TBL] [Abstract][Full Text] [Related]
13. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of dynamic contrast-enhanced MRI and its correlation with subtypes of breast cancer.
Li X; Fu P; Jiang M; Zhang J; Tan L; Ai T; Li X
Medicine (Baltimore); 2021 Dec; 100(51):e28109. PubMed ID: 34941052
[TBL] [Abstract][Full Text] [Related]
15. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI.
Wei F; Weidong F; Wenming Z; Lei H; Xiaosan C; Zhongliang M; Qianyun L; Huashan L
Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37497704
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
[TBL] [Abstract][Full Text] [Related]
18. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
Xu X; Wang P; Ma L; Shao Z; Zhang M
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
20. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
